Jpmorgan Chase & CO Aspira Women'S Health Inc. Transaction History

Jpmorgan Chase & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.4 - $1.09 $13,697 - $37,324	-34,243 Reduced 52.81%	30,596 $18,000
Q1 2022 May 11, 2022	BUY	$0.88 - $1.81 $31,846 - $65,502	36,189 Added 126.31%	64,839 $67,000
Q4 2021 Feb 10, 2022	BUY	$1.63 - $3.43 $118 - $250	73 Added 0.26%	28,650 $50,000
Q3 2021 Nov 12, 2021	BUY	$3.19 - $5.48 $91,160 - $156,601	28,577 New	28,577 $93,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.